Watch an interview with our President, David Kalfon

Watch an exclusive interview with David Kalfon, President of Inlog, conducted by Spectra Diagnostic.

🎬This video explores three key questions about our business, current progress and future strategy. Find out how Inlog continues its transformation in the laboratory management and blood transfusion sector. Watch an interview with David Kalfon.

🔬 What are Inlog‘s activities?

Inlog is distinguished by two main activities:

– Advanced laboratory management, with quality management software.

– Blood management, covering the transfusion chain of the Établissement Français du Sang in France and other countries. Inlog is committed to a mission-driven approach focused on patient safety and the well-being of its employees.

💼 Where is Inlog today?

Over the past three years, Inlog has doubled its turnover, increased its EBITDA and strengthened its workforce. Today, we have 75 employees divided between our headquarters in Lyon and our subsidiaries in Germany and Belgium

📈 What is our strategy for the next five years?

Over the next five years, Inlog plans to modernise its entire range of software solutions. We are developing new products incorporating the latest technologies, while exploring partnerships in artificial intelligence to improve outcomes for patients and in medical practices.

👀 We invite you to watch this interview to find out more about our initiatives and future prospects.